Literature DB >> 8290058

Ethical considerations raised by the approval of interferon beta-1b for the treatment of multiple sclerosis.

D E Goodkin1, G A Kanoti.   

Abstract

Entities:  

Keywords:  Biomedical and Behavioral Research; Cleveland Clinic Foundation; Professional Patient Relationship

Mesh：

Substances：

Year:  1994        PMID： 8290058     DOI： 10.1212/wnl.44.1.166

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  2 in total

Review 1.  Multiple sclerosis: it epidemiological, genetic, and health care impact.

Authors:  R Williams; A S Rigby; M Airey; M Robinson; H Ford
Journal:  J Epidemiol Community Health       Date:  1995-12       Impact factor: 3.710

2.  Implications of FDA Approval of a First Disease-Modifying Therapy for a Neurodegenerative Disease on the Design of Subsequent Clinical Trials.

Authors:  Joshua D Grill; Jason Karlawish
Journal:  Neurology       Date:  2021-06-04       Impact factor: 11.800
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.